Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Clinical trial NCT03233308 · COMPLETED
Trial details
- NCT number
- NCT03233308
- Sponsor
- Aerie Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-20
- Primary completion
- 2018-04-19
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.